Bull case
BCS would need investors to value it at roughly 18x earnings — about 7x more generous than today's 11x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where BCS stock could go
BCS would need investors to value it at roughly 18x earnings — about 7x more generous than today's 11x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
At 5x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
If investor confidence fades or macro conditions deteriorate, a 8x multiple contraction could push BCS down roughly 69% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Barclays is a major British multinational universal bank offering retail, corporate, and investment banking services globally. It generates revenue primarily through interest income from lending activities (roughly 60%) and fees from investment banking, wealth management, and credit card services (roughly 40%). Its key competitive advantage lies in its diversified revenue streams across retail and investment banking, coupled with its strong UK retail franchise and global investment banking presence.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $0.62/$0.50 | +24.0% | $25.1B/$9.4B | +167.9% |
| Q4 2025 | $0.56/$0.54 | +3.7% | $9.6B/$9.3B | +4.1% |
| Q1 2026 | $0.46/$0.42 | +9.5% | $9.7B/$9.4B | +2.8% |
| Q2 2026 | $0.76/$0.75 | +1.3% | $11.0B/$10.9B | +1.3% |
BCS beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $26 — implies +13.0% from today's price.
| Metric | BCS | S&P 500 | Financial Services | 5Y Avg BCS |
|---|---|---|---|---|
| Forward PE | 11.2x | 19.1x-41% | 10.5x | — |
| Trailing PE | 10.8x | 25.2x-57% | 13.4x-19% | 9.2x+17% |
| PEG Ratio | 0.29x | 1.75x-83% | 1.03x-72% | — |
| EV/EBITDA | 4.8x | 15.3x-68% | 11.4x-58% | 5.4x-11% |
| Price/FCF | — | 21.3x | 10.6x | 3.8x |
| Price/Sales | 2.3x | 3.1x-28% | 2.3x | 1.5x+47% |
| Dividend Yield | 3.42% | 1.88% | 2.68% | 4.59% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolBCS generates 9.2% ROE and 0.4% return on assets — the two primary signals for banking profitability. FCF-based metrics are not applicable to financial companies.
Revenue, profitability, and return on capital
ROIC, leverage, and debt serviceability
Traditional FCF and debt/FCF ratios are not meaningful for financial companies. Focus on ROE and ROA above.
How capital is returned to owners
All figures from the trailing twelve months. For financial companies, ROE and ROA are the primary health signals — FCF-based metrics are not applicable.
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated April 11, 2026
Barclays has significant exposure to the collapsed UK mortgage lender MFS, which is facing fraud allegations and potential double‑pledging of assets. This could trigger credit impairments and losses, potentially impacting the bank’s balance sheet and profitability.
Rising inflation, especially from energy prices and supply chain disruptions, combined with flat‑lining UK GDP heightens recession risks for cyclical banks like Barclays. Increased loan defaults and reduced lending activity could erode net interest income and capital buffers.
Barclays faces scrutiny from UK regulators over due diligence related to MFS and its sister companies, and has already incurred a €1.65 million fine from Germany’s BaFin. Ongoing investigations into potential securities law violations could result in additional penalties and reputational damage.
A material fall in UK property prices would threaten the sizable portion of Barclays’ retail and corporate credit exposure tied to the UK real estate market. Declining collateral values could increase credit losses and pressure the bank’s capital ratios.
Barclays’ exposure to private credit and asset‑backed lending is heightened by the MFS collapse, raising concerns about potential defaults in these non‑core portfolios. Losses in private credit could erode earnings and affect the bank’s risk‑adjusted returns.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated April 11, 2026
Barclays recently reported earnings that surpassed analyst expectations, delivering a positive EPS. This beat in earnings signals stronger profitability and operational efficiency.
The stock exhibits a robust uptrend and a classic bull flag pattern, indicating a potential breakout. It also shows strong trend agreement, relative performance, and trades above key moving averages.
Barclays offers an attractive dividend yield, appealing to income-focused investors. The consistent payout supports shareholder value and signals financial stability.
Management has set clear targets for income growth and efficiency savings, demonstrating confidence in future performance. These goals suggest a trajectory of improving profitability and cost control.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
BCS BCS Barclays PLC | $82.4B | 11.2x | -22.8% | — | Buy | +83.2% |
DB DB Deutsche Bank AG | $61.3B | 9.5x | -13.8% | — | Hold | -53.6% |
UBS UBS UBS Group AG | $140.3B | 13.8x | -19.3% | — | Buy | -47.9% |
HSB HSBC HSBC Holdings plc | $314.1B | 11.0x | -4.9% | — | Hold | -43.1% |
LYG LYG Lloyds Banking Group plc | $79.6B | 13.0x | +11.2% | — | Buy | -49.4% |
NWG NWG NatWest Group plc | $31.1B | 10.7x | -3.0% | — | Buy | — |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
BCS returns capital mainly through $6.1B/year in buybacks (10.6% buyback yield), with a modest 3.60% dividend — combining for 14.2% total shareholder yield. The dividend has grown for 5 consecutive years.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $0.31 | — | — | — |
| 2025 | $0.44 | +4.8% | 6.6% | 9.0% |
| 2024 | $0.42 | +8.5% | 9.9% | 14.4% |
| 2023 | $0.38 | +17.9% | 16.8% | 24.0% |
| 2022 | $0.33 | +96.1% | 12.6% | 18.4% |
Common questions answered from live analyst data and company financials.
Barclays PLC (BCS) is rated Buy by Wall Street analysts as of 2026. Of 24 analysts covering the stock, 18 rate it Buy or Strong Buy, 5 rate it Hold, and 1 rate it Sell or Strong Sell. The consensus 12-month price target is $44, implying +83.2% from the current price of $24. The bear case scenario is $7 and the bull case is $38.
The Wall Street consensus price target for BCS is $44 based on 24 analyst estimates. The high-end target is $44 (+83.2% from today), and the low-end target is $44 (+83.2%). The base case model target is $12.
BCS trades at 11.2x times forward earnings. The stock currently trades at a discount to the broader market. Based on current multiples versus the peer group, the relative model signals slightly undervalued. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for BCS in 2026 are: (1) MFS Credit Exposure — Barclays has significant exposure to the collapsed UK mortgage lender MFS, which is facing fraud allegations and potential double‑pledging of assets. (2) Macroeconomic Inflation & Recession — Rising inflation, especially from energy prices and supply chain disruptions, combined with flat‑lining UK GDP heightens recession risks for cyclical banks like Barclays. (3) Regulatory Scrutiny & Fines — Barclays faces scrutiny from UK regulators over due diligence related to MFS and its sister companies, and has already incurred a €1. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates BCS will report consensus revenue of $20.7B (-22.8% year-over-year) and EPS of $1.28 (-37.2% year-over-year) for the upcoming fiscal year. The following year, analysts project $16.1B in revenue.
A confirmed upcoming earnings date for BCS is not yet available. Check the Earnings section above for the most recent quarterly report dates and forward estimates.
Barclays PLC (BCS) generated $0 in free cash flow over the trailing twelve months. BCS returns capital to shareholders through dividends (3.6% yield) and share repurchases ($6.1B TTM).